ArticleAnnals of the rheumatic diseases2015

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.

Seoyoung C Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.